NCT02900170View on ClinicalTrials.gov

Can Rivaroxaban Lead to Anticoagulation-Related Nephropathy?

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

June 11, 2018

Study Completion Date

June 11, 2018

Conditions
Acute Kidney Injury
Trial Locations (1)

19141

Einstein Medical Center, Philadelphia

All Listed Sponsors
lead

Albert Einstein Healthcare Network

OTHER

NCT02900170 - Can Rivaroxaban Lead to Anticoagulation-Related Nephropathy? | Biotech Hunter | Biotech Hunter